{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:21:30Z","timestamp":1793042490091,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41401-024-01454-x","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:42:30Z","timestamp":1737358950000},"page":"1329-1344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Peptidoglycan isolated from the fruit of Lycium barbarum alleviates liver fibrosis in mice by regulating the TGF-\u03b2\/Smad7 signaling and gut microbiota"],"prefix":"10.1038","volume":"46","author":[{"given":"Ying-min","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-xue","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"1454_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"key":"1454_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151\u201371.","journal-title":"J Hepatol"},{"key":"1454_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789\u2013858.","journal-title":"Lancet"},{"key":"1454_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology. 2018;155:443\u201357.e17.","journal-title":"Gastroenterology"},{"key":"1454_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u201397.e10.","journal-title":"Gastroenterology"},{"key":"1454_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair:immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"1454_CR7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","volume":"158","author":"N Chalasani","year":"2020","unstructured":"Chalasani N, Abdelmalek MF, Garcia-Tsao G, Vuppalanchi R, Alkhouri N, Rinella M, et al. Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension. Gastroenterology. 2020;158:1334\u201345.e5.","journal-title":"Gastroenterology"},{"key":"1454_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","volume":"73","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials. J Hepatol. 2020;73:26\u201339.","journal-title":"J Hepatol"},{"key":"1454_CR9","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019;394:2184\u201396.","journal-title":"Lancet"},{"key":"1454_CR10","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/hep.31017","volume":"71","author":"JE Eaton","year":"2020","unstructured":"Eaton JE, Vuppalanchi R, Reddy R, Sathapathy S, Ali B, Kamath PS. Liver injury in patients with cholestatic liver disease treated with obeticholic acid. Hepatology. 2020;71:1511\u20134.","journal-title":"Hepatology"},{"key":"1454_CR11","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.cgh.2021.07.020","volume":"20","author":"ZM Younossi","year":"2022","unstructured":"Younossi ZM, Stepanova M, Nader F, Loomba R, Anstee QM, Ratziu V, et al. Obeticholic acid impact on quality of life in patients with nonalcoholic steatohepatitis: REGENERATE 18-month interim analysis. Clin Gastroenterol Hepatol. 2022;20:2050\u20138.e12.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1454_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/bmb\/ldaa006","volume":"133","author":"RW Chapman","year":"2020","unstructured":"Chapman RW, Lynch KD. Obeticholic acid-a new therapy in PBC and NASH. Br Med Bull. 2020;133:95\u2013104.","journal-title":"Br Med Bull"},{"key":"1454_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497\u2013509.","journal-title":"N Engl J Med"},{"key":"1454_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.","journal-title":"Nat Commun"},{"key":"1454_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","volume":"30","author":"C Hellerbrand","year":"1999","unstructured":"Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol. 1999;30:77\u201387.","journal-title":"J Hepatol"},{"key":"1454_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577\u201384.","journal-title":"Nature"},{"key":"1454_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/39369","volume":"389","author":"A Nakao","year":"1997","unstructured":"Nakao A, Afrakhte M, Mor\u00e9n A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997;389:631\u20135.","journal-title":"Nature"},{"key":"1454_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","volume":"89","author":"H Hayashi","year":"1997","unstructured":"Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997;89:1165\u201373.","journal-title":"Cell"},{"key":"1454_CR19","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","volume":"114","author":"A Moustakas","year":"2001","unstructured":"Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci. 2001;114:4359\u201369.","journal-title":"J Cell Sci"},{"key":"1454_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1083\/jcb.200307151","volume":"164","author":"W Shi","year":"2004","unstructured":"Shi W, Sun C, He B, Xiong W, Shi X, Yao D, et al. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol. 2004;164:291\u2013300.","journal-title":"J Cell Biol"},{"key":"1454_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","volume":"125","author":"S Dooley","year":"2003","unstructured":"Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003;125:178\u201391.","journal-title":"Gastroenterology"},{"key":"1454_CR22","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1111\/j.1582-4934.2008.00262.x","volume":"12","author":"J Hamzavi","year":"2008","unstructured":"Hamzavi J, Ehnert S, Godoy P, Ciuclan L, Weng H, Mertens PR, et al. Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice. J Cell Mol Med. 2008;12:2130\u201344.","journal-title":"J Cell Mol Med"},{"key":"1454_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/mt.2012.251","volume":"21","author":"AC Chung","year":"2013","unstructured":"Chung AC, Dong Y, Yang W, Zhong X, Li R, Lan HY. Smad7 suppresses renal fibrosis via altering expression of TGF-\u03b2\/Smad3-regulated microRNAs. Mol Ther. 2013;21:388\u201398.","journal-title":"Mol Ther"},{"key":"1454_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbadis.2008.10.010","volume":"1792","author":"J He","year":"2009","unstructured":"He J, Sun X, Qian KQ, Liu X, Wang Z, Chen Y. Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7. Biochim Biophys Acta. 2009;1792:56\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"1454_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI6094","volume":"104","author":"A Nakao","year":"1999","unstructured":"Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest. 1999;104:5\u201311.","journal-title":"J Clin Invest"},{"key":"1454_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.410","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Sun M, Li W, Liu C, Jiang Z, Gu P, et al. Rebalancing TGF-\u03b2\/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Clin Transl Med. 2021;11:e410.","journal-title":"Clin Transl Med"},{"key":"1454_CR27","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1111\/bph.14831","volume":"176","author":"J Liu","year":"2019","unstructured":"Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, et al. Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-\u03b2\/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol. 2019;176:4666\u201380.","journal-title":"Br J Pharmacol"},{"key":"1454_CR28","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1111\/liv.15715","volume":"43","author":"X Xu","year":"2023","unstructured":"Xu X, Guo Y, Luo X, Shen Z, Sun Z, Shen B, et al. Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7-mediated degradation of TGF\u03b2RI. Liver Int. 2023;43:2523\u201337.","journal-title":"Liver Int"},{"key":"1454_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"LX Yu","year":"2017","unstructured":"Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017;14:527\u201339.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1454_CR30","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513\u201324.","journal-title":"Gastroenterology"},{"key":"1454_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","volume":"37","author":"YH Paik","year":"2003","unstructured":"Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003;37:1043\u201355.","journal-title":"Hepatology"},{"key":"1454_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jhep.2011.11.013","volume":"56","author":"Q Zhu","year":"2012","unstructured":"Zhu Q, Zou L, Jagavelu K, Simonetto DA, Huebert RC, Jiang ZD, et al. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol. 2012;56:893\u20139.","journal-title":"J Hepatol"},{"key":"1454_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1096\/fj.14-259515","volume":"29","author":"M Mazagova","year":"2015","unstructured":"Mazagova M, Wang L, Anfora AT, Wissmueller M, Lesley SA, Miyamoto Y, et al. Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. FASEB J. 2015;29:1043\u201355.","journal-title":"FASEB J"},{"key":"1454_CR34","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/hep.26695","volume":"59","author":"S De Minicis","year":"2014","unstructured":"De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Candelaresi C, Trozzi L, et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology. 2014;59:1738\u201349.","journal-title":"Hepatology"},{"key":"1454_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2017;25:1054\u201362.e5.","journal-title":"Cell Metab"},{"key":"1454_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63:764\u201375.","journal-title":"Hepatology"},{"key":"1454_CR37","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60:940\u20137.","journal-title":"J Hepatol"},{"key":"1454_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59\u201364.","journal-title":"Nature"},{"key":"1454_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18754-5","volume":"11","author":"G Lee","year":"2020","unstructured":"Lee G, You HJ, Bajaj JS, Joo SK, Yu J, Park S, et al. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat Commun. 2020;11:4982.","journal-title":"Nat Commun"},{"key":"1454_CR40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut\u2013liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72:558\u201377.","journal-title":"J Hepatol"},{"key":"1454_CR41","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","volume":"54","author":"M Derrien","year":"2004","unstructured":"Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54:1469\u201376.","journal-title":"Int J Syst Evol Microbiol"},{"key":"1454_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71113-8","volume":"10","author":"I Kostopoulos","year":"2020","unstructured":"Kostopoulos I, Elzinga J, Ottman N, Klievink JT, Blijenberg B, Aalvink S, et al. Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro. Sci Rep. 2020;10:14330.","journal-title":"Sci Rep"},{"key":"1454_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01487-21","volume":"88","author":"E Luna","year":"2022","unstructured":"Luna E, Parkar SG, Kirmiz N, Hartel S, Hearn E, Hossine M, et al. Utilization efficiency of human milk oligosaccharides by human-associated Akkermansia is strain dependent. Appl Environ Microbiol. 2022;88:e0148721.","journal-title":"Appl Environ Microbiol"},{"key":"1454_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67:891\u2013901.","journal-title":"Gut"},{"key":"1454_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11684-022-0960-z","volume":"16","author":"Y Han","year":"2022","unstructured":"Han Y, Li L, Wang B. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives. Front Med. 2022;16:667\u201385.","journal-title":"Front Med"},{"key":"1454_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"S Keshavarz Azizi Raftar","year":"2021","unstructured":"Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, et al. The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spectr. 2021;9:e0048421.","journal-title":"Microbiol Spectr"},{"key":"1454_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19:625\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1454_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lfs.2017.11.047","volume":"192","author":"F Gan","year":"2018","unstructured":"Gan F, Liu Q, Liu Y, Huang D, Pan C, Song S, et al. Lycium barbarum polysaccharides improve CCl4-induced liver fibrosis, inflammatory response and TLRs\/NF-\u03baB signaling pathway expression in wistar rats. Life Sci. 2018;192:205\u201312.","journal-title":"Life Sci"},{"key":"1454_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijbiomac.2020.05.212","volume":"161","author":"H Zeng","year":"2020","unstructured":"Zeng H, Li P, Zhou L, Ding K. A novel pectin from Polygala tenuifolia blocks A\u03b242 aggregation and production by enhancing insulin-degradation enzyme and neprilysin. Int J Biol Macromol. 2020;161:35\u201343.","journal-title":"Int J Biol Macromol"},{"key":"1454_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2016.01.049","volume":"143","author":"D Luo","year":"2016","unstructured":"Luo D, Yuan X, Zeng Y, Nie K, Li Z, Wang Z. Structure elucidation of a major fucopyranose-rich heteropolysaccharide (STP-II) from Sargassum thunbergii. Carbohydr Polym. 2016;143:1\u20138.","journal-title":"Carbohydr Polym"},{"key":"1454_CR51","doi-asserted-by":"crossref","unstructured":"Huang C, Jing X, Wu Q, Ding K. Novel pectin-like polysaccharide from Panax notoginseng attenuates renal tubular cells fibrogenesis induced by TGF-\u03b2. Carbohydr Polym. 2022;276:118772.","DOI":"10.1016\/j.carbpol.2021.118772"},{"key":"1454_CR52","doi-asserted-by":"crossref","unstructured":"Wen C, Li T, Wang B, Jin C, Li S, Li Y, et al. A pectic polysaccharide isolated from Achyranthes bidentata is metabolized by human gut Bacteroides spp. Int J Biol Macromol. 2023;248:125785.","DOI":"10.1016\/j.ijbiomac.2023.125785"},{"key":"1454_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41181-021-00147-8","volume":"6","author":"R Cusnir","year":"2021","unstructured":"Cusnir R, Leresche M, Pilloud C, Straub M. An investigation of aspects of radiochemical purity of (99m)Tc-labelled human serum albumin nanocolloid. EJNMMI Radiopharm Chem. 2021;6:35.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"1454_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117255","volume":"253","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zhang Y, Liu Y, Wang J, Cui Z, Pan X, et al. Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase. Carbohydr Polym. 2021;253:117255.","journal-title":"Carbohydr Polym"},{"key":"1454_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126357","volume":"253","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wu N, Wang J, Chen Z, Wu Z, Song M, et al. Gastrointestinal metabolism characteristics and mechanism of a polysaccharide from Grifola frondosa. Int J Biol Macromol. 2023;253:126357.","journal-title":"Int J Biol Macromol"},{"key":"1454_CR56","doi-asserted-by":"publisher","first-page":"re10","DOI":"10.1126\/scisignal.aad0416","volume":"8","author":"RJ Akhurst","year":"2015","unstructured":"Akhurst RJ, Padgett RW. Matters of context guide future research in TGF\u03b2 superfamily signaling. Sci Signal. 2015;8:re10.","journal-title":"Sci Signal"},{"key":"1454_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.282","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018;50:e450.","journal-title":"Exp Mol Med"},{"key":"1454_CR58","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110:9066\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1454_CR59","doi-asserted-by":"publisher","first-page":"121637","DOI":"10.1016\/j.carbpol.2023.121637","volume":"326","author":"X Dai","year":"2024","unstructured":"Dai X, Du Z, Jin C, Tang B, Chen X, Jing X, et al. Inulin-like polysaccharide ABWW may impede CCl4 induced hepatic stellate cell activation through mediating the FAK\/PI3K\/AKT signaling pathway in vitro & in vivo. Carbohydr Polym. 2024;326:121637.","journal-title":"Carbohydr Polym"},{"key":"1454_CR60","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrmicro3050","volume":"11","author":"A El Kaoutari","year":"2013","unstructured":"El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol. 2013;11:497\u2013504.","journal-title":"Nat Rev Microbiol"},{"key":"1454_CR61","first-page":"002","volume":"Suppl 1","author":"DC Dallas","year":"2012","unstructured":"Dallas DC, Sela D, Underwood MA, German JB, Lebrilla C. Protein-linked glycan degradation in infants fed human milk. J Glycom Lipidom. 2012;Suppl 1:002.","journal-title":"J Glycom Lipidom"},{"key":"1454_CR62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1126\/science.aau5812","volume":"362","author":"CL Gentile","year":"2018","unstructured":"Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776\u201380.","journal-title":"Science"},{"key":"1454_CR63","first-page":"3502","volume":"57","author":"J Yan","year":"2022","unstructured":"Yan J, Sheng L, Li Y, Bao Y, Li H. Mechanism study of Si Miao Formula on alleviating insulin resistance by increasing the abundance of Akkermansia muciniphila in mice. Acta Pharm Sin B. 2022;57:3502\u201312.","journal-title":"Acta Pharm Sin B"},{"key":"1454_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijbiomac.2014.05.034","volume":"69","author":"J Xiao","year":"2014","unstructured":"Xiao J, Zhu Y, Liu Y, Tipoe GL, Xing F, So KF. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway. Int J Biol Macromol. 2014;69:73\u201378.","journal-title":"Int J Biol Macromol"},{"key":"1454_CR65","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1038\/nutd.2013.22","volume":"3","author":"J Xiao","year":"2013","unstructured":"Xiao J, Liong EC, Ching YP, Chang RC, Fung ML, Xu AM, et al. Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced-induced injury. Nutr Diabetes. 2013;3:e81.","journal-title":"Nutr Diabetes"},{"key":"1454_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/srep05587","volume":"4","author":"J Xiao","year":"2014","unstructured":"Xiao J, Xing F, Huo J, Fung ML, Liong EC, Ching YP, et al. Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model. Sci Rep. 2014;4:5587.","journal-title":"Sci Rep"},{"key":"1454_CR67","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ijbiomac.2021.05.066","volume":"183","author":"LL Gao","year":"2021","unstructured":"Gao LL, Ma JM, Fan YN, Zhang YN, Ge R, Tao XJ, et al. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. Int J Biol Macromol. 2021;183:1379\u201392.","journal-title":"Int J Biol Macromol"},{"key":"1454_CR68","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijbiomac.2018.09.151","volume":"120","author":"J Xiao","year":"2018","unstructured":"Xiao J, Wang F, Liong EC, So KF, Tipoe GL. Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3\/6 pathways in a methionine choline deficient diet steatohepatitis mouse model. Int J Biol Macromol. 2018;120:1480\u20139.","journal-title":"Int J Biol Macromol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01454-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:02:45Z","timestamp":1745586165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01454-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01454-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}